Coxsackievirus B Type 4 Infection in β Cells Downregulates the Chaperone Prefoldin URI to Induce a MODY4-like Diabetes via


Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
20 10 2020
Historique:
received: 29 06 2018
revised: 06 08 2020
accepted: 22 09 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 19 11 2020
Statut: epublish

Résumé

Enteroviruses are suspected to contribute to insulin-producing β cell loss and hyperglycemia-induced diabetes. However, mechanisms are not fully defined. Here, we show that coxsackievirus B type 4 (CVB4) infection in human islet-engrafted mice and in rat insulinoma cells displays loss of unconventional prefoldin RPB5 interactor (URI) and PDX1, affecting β cell function and identity. Genetic URI ablation in the mouse pancreas causes PDX1 depletion in β cells. Importantly, diabetic PDX1 heterozygous mice overexpressing URI in β cells are more glucose tolerant. Mechanistically, URI loss triggers estrogen receptor nuclear translocation leading to DNA methyltransferase 1 (DNMT1) expression, which induces

Identifiants

pubmed: 33205075
doi: 10.1016/j.xcrm.2020.100125
pii: S2666-3791(20)30167-1
pmc: PMC7659558
doi:

Substances chimiques

Capsid Proteins 0
Homeodomain Proteins 0
Repressor Proteins 0
Trans-Activators 0
Uri1 protein, mouse 0
VP1 protein, enterovirus B 0
pancreatic and duodenal homeobox 1 protein 0
DNA (Cytosine-5-)-Methyltransferase 1 EC 2.1.1.37
Dnmt1 protein, mouse EC 2.1.1.37
Glucose IY9XDZ35W2
Procainamide L39WTC366D

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100125

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI116920
Pays : United States

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Virology. 2004 Nov 24;329(2):381-94
pubmed: 15518817
Biol Proced Online. 2009 Dec 03;11:3-31
pubmed: 19957062
N Engl J Med. 2020 Aug 20;383(8):789-790
pubmed: 32530585
Diabetol Metab Syndr. 2018 May 10;10:40
pubmed: 29760789
Cell Metab. 2014 Feb 4;19(2):259-71
pubmed: 24506867
Cell Metab. 2017 Mar 7;25(3):622-634
pubmed: 28215845
N Engl J Med. 1979 May 24;300(21):1173-9
pubmed: 219345
Proc Soc Exp Biol Med. 1955 Jan;88(1):22-4
pubmed: 14357332
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5115-20
pubmed: 17360338
Acta Diabetol. 2010 Sep;47(3):193-9
pubmed: 19333547
Diabetologia. 1981 May;20(5):573-7
pubmed: 7026332
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415896
Nature. 2010 Apr 22;464(7292):1149-54
pubmed: 20364121
Cell Metab. 2014 May 6;19(5):872-82
pubmed: 24746806
Diabetes. 2009 Oct;58(10):2292-302
pubmed: 19587358
Pediatr Diabetes. 2012 Jun;13(4):334-9
pubmed: 22059423
J Biol Chem. 2017 Apr 7;292(14):5957-5969
pubmed: 28242761
Diabetes. 2015 Apr;64(4):1444-58
pubmed: 25377875
Dev Cell. 2013 Jul 15;26(1):3-7
pubmed: 23867225
Science. 2019 May 31;364(6443):
pubmed: 31147493
Cell Metab. 2019 Mar 5;29(3):755-768.e5
pubmed: 30713109
Cell Stem Cell. 2018 Jan 4;22(1):78-90.e4
pubmed: 29304344
Cell Metab. 2019 Mar 5;29(3):769-783.e4
pubmed: 30713110
Nat Genet. 2018 May;50(5):699-707
pubmed: 29662164
FEBS Lett. 2011 May 6;585(9):1269-75
pubmed: 21459093
Virology. 2008 Jun 5;375(2):480-91
pubmed: 18378272
Diabetes. 2015 Apr;64(4):1358-69
pubmed: 25392246
Science. 2003 Nov 14;302(5648):1208-12
pubmed: 14615539
J Clin Invest. 2008 Jun;118(6):2316-24
pubmed: 18464933
Cell Death Dis. 2016 Nov 3;7(11):e2452
pubmed: 27809303
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13525-13530
pubmed: 29203669
JCI Insight. 2018 Aug 9;3(15):
pubmed: 30089716
Sci Rep. 2019 Mar 6;9(1):3619
pubmed: 30842440
Cell Rep. 2017 Apr 18;19(3):584-600
pubmed: 28423321
Endocrinology. 2004 Feb;145(2):667-78
pubmed: 14592952
Nat Rev Endocrinol. 2019 Nov;15(11):635-650
pubmed: 31534209
Mol Cell. 2007 Oct 12;28(1):28-40
pubmed: 17936702
J Endocr Soc. 2017 Sep 11;1(10):1272-1286
pubmed: 29264452
Diabetologia. 2009 Jun;52(6):1143-51
pubmed: 19266182
Mol Cell Biol. 1997 Oct;17(10):6002-13
pubmed: 9315659
Physiol Behav. 2018 Apr 1;187:20-23
pubmed: 28843891
Cancer Cell. 2016 Jul 11;30(1):161-175
pubmed: 27411590
Biochem Biophys Res Commun. 2012 Oct 12;427(1):47-53
pubmed: 22975348
Cell Mol Life Sci. 2013 Nov;70(21):4169-80
pubmed: 23775130
Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1126-37
pubmed: 19808654
Diabetes Res Clin Pract. 2020 Jun;164:108166
pubmed: 32339533
Diabetologia. 2002 Mar;45(3):309-26
pubmed: 11914736
Diabetologia. 2019 May;62(5):744-753
pubmed: 30675626
Cancer Cell. 2016 Aug 8;30(2):290-307
pubmed: 27505673
J Biol Chem. 2005 Dec 9;280(49):40749-56
pubmed: 16230360
Trends Endocrinol Metab. 2013 Jul;24(7):324-31
pubmed: 23647931
BMJ. 2011 Feb 03;342:d35
pubmed: 21292721
Expert Rev Proteomics. 2013 Aug;10(4):365-80
pubmed: 23992419
J Clin Invest. 2010 Nov;120(11):4031-9
pubmed: 20978346
Curr Diabetes Rev. 2020;16(7):770-778
pubmed: 31544697
Diabetes. 2002 Dec;51 Suppl 3:S320-5
pubmed: 12475770
Nat Rev Endocrinol. 2010 May;6(5):279-89
pubmed: 20351698
Nature. 2014 Oct 23;514(7523):503-7
pubmed: 25141178
J Biol Chem. 2006 Feb 3;281(5):2649-53
pubmed: 16326700
Diabetes. 2013 Jul;62(7):2471-80
pubmed: 23569174
Genes Dev. 1998 Jun 15;12(12):1763-8
pubmed: 9637677
Genes Dev. 2011 Aug 15;25(16):1680-5
pubmed: 21852533
Cell. 2012 Sep 14;150(6):1223-34
pubmed: 22980982
Horm Res Paediatr. 2011;76 Suppl 1:57-64
pubmed: 21778751
Diabetes Metab Res Rev. 2017 Sep;33(6):
pubmed: 28303682
N Engl J Med. 2000 Feb 3;342(5):301-7
pubmed: 10655528
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
Int J Oncol. 2013 Dec;43(6):2073-81
pubmed: 24141649
BMC Dev Biol. 2001;1:4
pubmed: 11299042
Cardiovasc Surg. 2003 Feb;11(1):12-8
pubmed: 12543566
Carcinogenesis. 2011 Jun;32(6):829-35
pubmed: 21362628
Diabetes. 2015 May;64(5):1682-7
pubmed: 25422108
Mol Endocrinol. 2012 Jul;26(7):1203-12
pubmed: 22570331
Viruses. 2019 Jul 02;11(7):
pubmed: 31269669
Dev Cell. 2015 Apr 6;33(1):67-81
pubmed: 25816988
Diabetes. 2002 Feb;51 Suppl 1:S138-43
pubmed: 11815473
J Clin Endocrinol Metab. 2000 Jan;85(1):432-40
pubmed: 10634421
J Clin Invest. 2013 Mar;123(3):1275-84
pubmed: 23434589
Diabetologia. 2014 Feb;57(2):392-401
pubmed: 24190581
Science. 2018 Mar 23;359(6382):1376-1383
pubmed: 29519916
Cancer Cell. 2014 Dec 8;26(6):826-839
pubmed: 25453901
J Clin Endocrinol Metab. 2016 Mar;101(3):1044-54
pubmed: 26713822
Nat Med. 2017 Apr;23(4):501-507
pubmed: 28263308
Oncotarget. 2017 Feb 21;8(8):12620-12636
pubmed: 28147344
Bioinformatics. 2005 Nov 1;21(21):4067-8
pubmed: 16141249
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12236-41
pubmed: 12221286
J Diabetes Complications. 2001 Nov-Dec;15(6):328-35
pubmed: 11711327

Auteurs

Hugo Bernard (H)

Molecular Oncology Programme, Growth Factors, Nutrients and Cancer Group, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid 28029, Spain.

Ana Teijeiro (A)

Molecular Oncology Programme, Growth Factors, Nutrients and Cancer Group, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid 28029, Spain.

Almudena Chaves-Pérez (A)

Molecular Oncology Programme, Growth Factors, Nutrients and Cancer Group, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid 28029, Spain.

Cristian Perna (C)

Department of Pathology, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid 28034, Spain.

Basanthi Satish (B)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Anna Novials (A)

IDIBAPS, August Pi i Sunyer Biomedical Research Institute and, CIBERDEM, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Barcelona, Spain.

Jennifer P Wang (JP)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Nabil Djouder (N)

Molecular Oncology Programme, Growth Factors, Nutrients and Cancer Group, Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid 28029, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH